Access To Medicine Foundation

Often searched

Index ranking

Vacancies

10 year analysis

  • Healthcare inequity
    • How big is the problem?
    • How we drive change
    • Our story
    • Our impact
    • How big is the problem?
    • How we drive change
    • Our story
    • Our impact
  • Become a catalyst
    • Investors
    • Companies
    • Government & policymakers
    • Events & engagements
    • Investors
    • Companies
    • Government & policymakers
    • Events & engagements
  • Sectors and research
    • R&D-based pharma companies
    • Medical gas companies
    • Generic medicine manufacturers
    • Diagnostics companies
    • Vaccine manufacturers
    • Research hub
    • Company profiles & report cards
    • R&D-based pharma companies
    • Medical gas companies
    • Generic medicine manufacturers
    • Diagnostics companies
    • Vaccine manufacturers
    • Research hub
    • Company profiles & report cards
  • Cross-Sector Programmes
    • Antimicrobial resistance
    • Diabetes care
    • Antimicrobial resistance
    • Diabetes care
  • On the pulse of global health
    • Access insights
    • The Health Equity podcast
    • Access insights
    • The Health Equity podcast
  • News
  • Our team
  • Featured insights
  • Governance & financials
  • Vacancies
  • Media coverage
  • FAQ
  • Contact us
24 August 2016

Jayasree K. Iyer to chair panel on barriers to NCDs in sub-Saharan Africa

On 26 August in Nairobi, African leaders and the Japanese government will come together to discuss trade, investment and development at teh sixth Tokyo International Conference on African Development (TICAD VI). In a TICAD side-event, hosted by Takeda, Jayasree K. Iyer, will chair a panel discussion about the challenge of treating non-communicable diseases in sub-Saharan Africa. Given the recent Ebola crisis and emergence of Zika, the need for stronger health systems across the continent is once again high on the agenda.

“For the poor in Africa, the barriers to treatment for lifestyle diseases, such as cancer, diabetes or heart disease, are generally very high,” says Jayasree. “Diagnosis and treatment are often complex and expensive, even where the facilities exist within reasonable distances. In TICAD, we have a forum for talking about real solutions. There are plenty of good ideas and best practices out there that need more attention.”

Jayasree will chair a multi-disciplinary panel of experts, including academics, NGO leaders, government ministers, pharma industry representatives and health practitioners from sub-Saharan Africa. Together, they will unpick the main challenges to providing access to care for patients with non-communicable diseases:

  1. What prevents people in Africa from accessing treatments for cancer, diabetes and other non-communicable diseases?

  2. What does best practice look like for improving African healthcare systems?

  3. What role is there for public-private partnerships and what are the alternatives?

  4. What is the role for ‘Big Data’ in improving healthcare systems?

The panelists are:

  • Marc Dybul, Executive Director, Global Fund

  • Dr Meshack Ndirangu, Kenya Country Director, AMREF health Africa

  • Dr. Patricia Odero, East Africa Regional Director, Social Entrepreneurship Accelerator, Duke University

  • Dr. Kibachio Joseph Mwangi, Head of NCD Division, Ministry of Health Kenya

  • Dr Emmanuel Ndahiro, Rwanda Military Hospital

  • Prof. Raj Jutley, Chairman, Pan-Africa Heart Foundation

  • Giles Platford, President, Emerging Markets, Takeda

  • Dr. Chite Asirwa, Medical Co-Director, Ampath Hematology Oncology.


Access to Medicine Foundation

Interested in our work?

Access to Medicine Foundation is funded by

Terms & conditions

Privacy & cookie policy

Disclaimer

Copyright 2004 - 2025 Access to Medicine Foundation - All Rights Reserved